Clinical Trials on COL4A1-Related Brain Small Vessel Disease With Haemorrhage in New Zealand
Total 79 results
-
The George InstituteUniversity of SydneyTerminatedStroke | Hypertension | Cerebral Small Vessel Diseases | Vascular Dementia | Intracerebral HemorrhageAustralia
-
The George InstituteUniversity of SydneyTerminatedHypertension | Cerebral Small Vessel Diseases | Dementia, Vascular | Stroke Hemorrhagic | Cognitive Decline | Intracerebral HemorrhageAustralia, Netherlands
-
Icahn School of Medicine at Mount SinaiRecruitingTranscranial Ultrasound With Sonolucent Cranioplasty | TUSCUnited States
-
University of Massachusetts, WorcesterYale UniversityWithdrawnIschemic Stroke | Hemorrhagic Stroke | Intracerebral Hemorrhage | Ischaemic Stroke With ComaUnited States
-
Icahn School of Medicine at Mount SinaiCompletedSubarachnoid Hemorrhage | Delayed Cerebral Ischemia | Cerebral VasospasmUnited States
-
University of PennsylvaniaNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsCompletedMicroscopic Polyangiitis (MPA) | Granulomatosis With Polyangiitis (Wegener's) (GPA)United States, Belgium, France, United Kingdom, Denmark, Canada, Japan, Australia, New Zealand, Sweden, Czechia, Italy, Greece, Mexico, Norway
-
InflaRx GmbHIqvia Pty LtdTerminatedGranulomatosis With Polyangiitis (GPA) | Microscopic Polyangiitis (MPA)United States, Canada
-
Johns Hopkins UniversityBoston University; Mayo Clinic; University of Alabama at Birmingham; University... and other collaboratorsTerminatedMicroscopic Polyangiitis | Granulomatosis With PolyangiitisUnited States, Netherlands
-
Cambridge University Hospitals NHS Foundation TrustUniversity of Pennsylvania; Roche Pharma AG; Genentech, Inc.; Arthritis Research...CompletedMicroscopic Polyangiitis | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | Wegener GranulomatosisUnited States, Canada, United Kingdom, Sweden, New Zealand, Ireland, Australia, Italy, Czechia, Japan
-
Yale UniversityCompletedSmall Vessel Disease of Diabetes MellitusUnited States
-
Hoffmann-La RocheCompletedGranulomatosis With PolyangiitisUnited States, Canada, United Kingdom, Germany, Italy, Serbia, Turkey, France
-
Genentech, Inc.CompletedMicroscopic Polyangiitis | Granulomatosis With PolyangiitisUnited States
-
NICHD Neonatal Research NetworkEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedIntracranial Hemorrhages | Infant, Very Low Birth Weight | Infant, Small for Gestational Age | Infant, Premature | Infant, NewbornUnited States
-
Bellus Health IncNational Institute of Neurological Disorders and Stroke (NINDS)CompletedStroke | Neurologic Diseases, GeneralUnited States
-
National Institute of Allergy and Infectious Diseases...Genentech, Inc.; Immune Tolerance Network (ITN)CompletedVasculitis | Wegener's Granulomatosis | Microscopic PolyangiitisUnited States, Netherlands
-
Eunice Kennedy Shriver National Institute of Child...Unknown
-
NICHD Neonatal Research NetworkNational Center for Research Resources (NCRR)CompletedIntracranial Hemorrhages | Infant, Small for Gestational Age | Infant, Premature | Infant, Low Birth Weight | Infant, NewbornUnited States
-
NICHD Neonatal Research NetworkNational Center for Research Resources (NCRR)CompletedCerebral Palsy | Intracranial Hemorrhages | Infant, Small for Gestational Age | Infant, Premature | Leukomalacia, Periventricular | Infant, Low Birth Weight | Infant, NewbornUnited States
-
Amicus TherapeuticsCompleted
-
ShireActive, not recruiting
-
NYU Langone HealthCompleted
-
Perminder SachdevMelbourne Health; Royal Brisbane and Women's Hospital; The University of Queensland and other collaboratorsRecruiting
-
SanofiRecruitingFabry's DiseaseUnited States
-
Michio HiranoSanthera PharmaceuticalsCompletedMELAS SyndromeUnited States
-
University of British ColumbiaUniversity of Oxford; BC Childrens Hospital Research InstituteRecruitingMicroscopic Polyangiitis | Polyarteritis Nodosa | Eosinophilic Granulomatosis With Polyangiitis | Takayasu Arteritis | Wegeners Granulomatosis (Granulomatosis With Polyangiitis) | Primary CNS Vasculitis | Unclassified VasculitisCanada, United States, Thailand, United Kingdom, Germany, India, Denmark
-
Amicus TherapeuticsApproved for marketingPhysician Initiated Expanded Access Request for Migalastat in Individual Patients With Fabry DiseaseFabry DiseaseUnited States, Australia
-
Amicus TherapeuticsCompletedFabry DiseaseUnited States
-
Human Genome Sciences Inc., a GSK CompanyGlaxoSmithKlineCompletedVasculitisUnited States, Australia, France, Spain, Italy, Peru, Belgium, Canada, Germany, Romania, Mexico, United Kingdom, Hungary, Ireland, Poland, Switzerland, Czechia, Russian Federation, Norway, Sweden
-
Eisai LimitedCompletedCognitive ImpairmentUnited States, Spain, Australia
-
University of PennsylvaniaNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsRecruitingGiant Cell Arteritis | Microscopic Polyangiitis | Polyarteritis Nodosa | Takayasu's Arteritis | Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss) | Granulomatosis With Polyangiitis (Wegener's)United States, Canada, Turkey
-
ShireNo longer available
-
AVROBIOTerminatedFabry DiseaseUnited States, Australia, Brazil
-
Amicus TherapeuticsTerminatedFabry DiseaseUnited Kingdom, United States, Australia, Brazil, France
-
Genzyme, a Sanofi CompanyCompletedFabry DiseaseUnited States, France, Netherlands, Puerto Rico, United Kingdom
-
PfizerCompletedCerebral Amyloid AngiopathyCanada, United States, Netherlands, France, United Kingdom
-
Freeline TherapeuticsTerminatedLysosomal Storage Diseases | Fabry DiseaseUnited States, Norway, Germany, Austria, United Kingdom, Italy, Canada
-
Sangamo TherapeuticsEnrolling by invitationFabry Disease | Fabry Disease, Cardiac VariantUnited States, Australia, United Kingdom
-
ShireCompletedFabry DiseaseUnited States, United Kingdom, Australia, Czechia, Finland, Paraguay, Poland, Slovenia
-
University of Wisconsin, MadisonNational Institute on Aging (NIA)Recruiting
-
ShireCompletedFabry DiseaseCanada, United States
-
Sangamo TherapeuticsActive, not recruitingFabry DiseaseUnited States, United Kingdom, Taiwan, Australia, Germany, Italy, Canada
-
Amicus TherapeuticsTerminatedFabry DiseaseAustralia, United States, Italy, Spain, Belgium, Turkey, Brazil, Argentina, United Kingdom, Denmark, France, Canada, Egypt
-
Tisento TherapeuticsChildren's Hospital of PhiladelphiaTerminated
-
Amicus TherapeuticsCompletedOpen-Label Extension Study of the Long-Term Effects of Migalastat HCL in Patients With Fabry DiseaseFabry DiseaseUnited States, Austria, United Kingdom, Argentina, Australia, Belgium, Brazil, Canada, Denmark, Egypt, France, Italy, Japan, Spain, Turkey
-
Amicus TherapeuticsCompletedFabry DiseaseUnited States, Italy, Spain, Turkey, Brazil, Canada, United Kingdom, France, Poland, Australia, Egypt, Argentina, Denmark
-
Genzyme, a Sanofi CompanyRecruitingFabry DiseaseCroatia, United States, Argentina, Australia, Belgium, Bulgaria, Canada, Germany, Hong Kong, India, Indonesia, Korea, Republic of, Kuwait, Malaysia, Philippines, Poland, Romania, Singapore, Slovakia, Taiwan, Thailand, United Kingdom, Vietn... and more
-
Genzyme, a Sanofi CompanyCompletedFabry DiseaseUnited States, United Kingdom, Canada, Czech Republic, Hungary, Poland
-
Tisento TherapeuticsNot yet recruitingMitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS Syndrome)United States, Australia, Italy, Germany, Canada, United Kingdom
-
Genzyme, a Sanofi CompanyCRL/MedinetTerminatedFabry Disease | Chronic Kidney Disease, Stage IV (Severe)United States
-
Genzyme, a Sanofi CompanyCompletedFabry DiseaseUnited States, United Kingdom, Canada, Hungary, Poland, Czech Republic